Actively Recruiting
Deep Versus Moderate Neuromuscular Blocking
Led by Menoufia University · Updated on 2026-03-20
88
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aimed for Determination of the impacts of deep neuromuscular blockade (DNMB) on surgical outcomes, consumption of perioperative opioid analgesia, and serum levels of inflammatory cytokines in comparison to moderate NMB (MNMB).
CONDITIONS
Official Title
Deep Versus Moderate Neuromuscular Blocking
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women who will be admitted to undergo elective hysterectomy
- ASA grade I or II
- Body mass index (BMI) of <35 kg/m2
You will not qualify if you...
- Hemoglobin concentration of ≤7 gm%
- Presence of neuromuscular disorders
- Uncontrolled medical diseases
- Autoimmune diseases or maintenance on immunosuppressant therapy
- Refusal to sign the written consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Medicine Menoufia University
Menoufia, Eg.mn, Egypt, 32511
Actively Recruiting
Research Team
R
Rabab Habeeb, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here